Related Experiment Videos
Yeast mutant defective in phosphatidylserine synthesis
The Journal of Biological Chemistry
|July 25, 1980
Summary
The Saccharomyces cerevisiae cho1 mutant shows a significant reduction in phosphatidylserine synthesis. This yeast mutant utilizes an alternative pathway for phospholipid production, impacting overall lipid metabolism.
Area of Science:
- Biochemistry
- Molecular Biology
- Yeast Genetics
Background:
- Phospholipid biosynthesis is crucial for cellular function.
- Saccharomyces cerevisiae is a model organism for studying eukaryotic cell biology.
- The cho1 mutant lacks the ability to synthesize phosphatidylserine.
Purpose of the Study:
- To investigate phospholipid biosynthesis in the Saccharomyces cerevisiae cho1 mutant.
- To understand the metabolic consequences of lacking phosphatidylserine synthesis.
- To elucidate the alternative pathways utilized for phospholipid production.
Main Methods:
- In vitro cell-free synthesis assays to measure enzyme activities.
- Analysis of phospholipid synthesis, accumulation, and turnover in vivo.
- Comparison of wild-type and cho1 mutant strains.
Main Results:
- The cho1 mutant exhibits a >10-fold reduction in phosphatidylserine synthesis in vitro.
- Other phospholipid biosynthetic activities are normal or elevated.
- In vivo studies reveal altered phospholipid patterns, including elevated phosphatidylinositol and phosphatidylcholine synthesis.
- Increased turnover rate of phosphatidylcholine observed in the mutant.
Conclusions:
- The cho1 mutant primarily relies on the Kennedy and Weiss pathway for phosphatidylethanolamine and phosphatidylcholine production, bypassing phosphatidylserine.
- Disruption of phosphatidylserine synthesis significantly alters yeast phospholipid metabolism.
- This study highlights the importance of phosphatidylserine as an intermediate in yeast phospholipid biosynthesis.